We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$983M
AUM Growth
-$17.1M
Cap. Flow
-$12M
Cap. Flow %
-1.22%
Top 10 Hldgs %
32.2%
Holding
127
New
1
Increased
30
Reduced
69
Closed
1

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$6.33M
2
AMT icon
American Tower
AMT
+$2.44M
3
AMD icon
Advanced Micro Devices
AMD
+$1.5M
4
TMO icon
Thermo Fisher Scientific
TMO
+$810K
5
PEP icon
PepsiCo
PEP
+$796K

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$3.96M
2
BDX icon
Becton Dickinson
BDX
+$2.95M
3
NVDA icon
NVIDIA
NVDA
+$2.23M
4
AAPL icon
Apple
AAPL
+$1.47M
5
META icon
Meta Platforms (Facebook)
META
+$1.42M

Sector Composition

Rank Sector Weight
1 Technology 30.47%
2 Industrials 14.96%
3 Healthcare 13.62%
4 Consumer Discretionary 11.76%
5 Consumer Staples 10.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLB icon
126
SLB Ltd
SLB
$73.6B
$201K 0.02%
5,255
-1,000
-16% -$42K
GSK icon
127
GSK
GSK
$104B
– –
-96,753
Closed -$3.96M
2 3 4 5
6

Similar funds

OCAI
O'Connor Alternative Investments New York $1.17B AUM
BONST
Bank of Nova Scotia Trust Toronto, Ontario, Canada $1.16B AUM 27.04% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.17B AUM 16.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jacobs & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Jacobs & Co held 127 positions worth $983M, down 1.7% from $1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 1.6%. Jacobs & Co opened 1 new position and exited 1, leaving the 127-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Industrials and Healthcare.

  • Jacobs & Co's largest Q4 2024 buy was Blackrock: 198 shares worth $202K.
  • Jacobs & Co added most to Eli Lilly in Q4 2024, an estimated $6.33M increase.
  • Jacobs & Co's biggest Q4 2024 reduction was Becton Dickinson, cutting an estimated $2.95M.
  • Jacobs & Co fully exited GSK in Q4 2024, selling an estimated $3.96M.
  • Jacobs & Co's ten largest holdings make up 32% of its $983M portfolio in Q4 2024.
  • Jacobs & Co opened 1 new position and closed 1 in Q4 2024.
  • Jacobs & Co's portfolio value fell 1.7% quarter-over-quarter to $983M.

Based on Jacobs & Co's 13F filing for Q4 2024, filed 10 Jan 2025.